CRDL Cardiol Therapeutics Inc

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2025

 

Commission File Number:  001-40712

 

Cardiol Therapeutics Inc. 

(Name of registrant)

 

602-2265 Upper Middle Road East 

Oakville, Ontario L6H 0G5 

Canada

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

¨   Form 20-F

x   Form 40-F

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	CARDIOL THERAPEUTICS INC.
	(Registrant)
Date:  March 14, 2025	By:	/s/ Chris Waddick
		Name:	Chris Waddick
		Title:	Chief Financial Officer

 

 

Form 6-K Exhibit Index

 

Exhibit Number		Document Description
99.1		Notice of Meeting and Record Date, dated March 14, 2025

 

 

 

Exhibit 99.1

 

March 14, 2025

 

Filed via SEDAR+

 

To All Applicable Exchanges and Securities Administrators

 

Subject:	Cardiol Therapeutics Inc. (the "Issuer")
	Notice of Meeting and Record Date

 

Dear Sir/Madam:

 

We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:

 

Meeting Type:	Annual General Meeting
Meeting Date:	May 28, 2025
Record Date for Notice of Meeting:	April 10, 2025
Record Date for Voting (if applicable):	April 10, 2025
Beneficial Ownership Determination Date:	April 10, 2025
Class of Securities Entitled to Vote:	Class A Common
ISIN:	CA14161Y2006
Issuer sending proxy materials directly to NOBOs:	No
Issuer paying for delivery to OBOs:	Yes
Notice and Access for Beneficial Holders:	Yes
Beneficial Holders Stratification Criteria:	Not Applicable
Notice and Access for Registered Holders:	Yes
Registered Holders Stratification Criteria:	Not Applicable

 

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

 

Yours truly,

 

Odyssey Trust Company

as agent for Cardiol Therapeutics Inc.

 

 

---